Mind Body Program for Vascular Disease
Withdrawn before enrolling · Not applicable
Conditions studied: Peripheral Arterial Disease, Peripheral Vascular Diseases
In brief
The purpose of the current study is to conduct a proof-of-concept test regarding the delivery of a Mind Body Program for vascular disease, focusing on support for depression, stress, and adherence, as part of patients' chronic disease management for peripheral artery disease (PAD).
Key facts
- Study ID
- NCT05757752
- Run by
- Yale University
- People needed
- 0
- Starts
- 2023-01-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-04-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Rutherford score 1-4 (mild-severe claudication, or ischemic rest pain)
- Resting ankle-brachial index assessment ≤0.90 or drop in post-exercise ankle pressure ≥20 mmHg or non-compressible ankle-brachial index (≥1.30) or toe brachial index less than 0.70 in the past year
- Positive depression screening result (positive PHQ-9 result ≥10) or high stress screening result (10-item Perceived Stress Scale Score ≥27)
You may not qualify if…
- Not speaking either English or Spanish
- Age ≥18 years
- Currently incarcerated
- Current alcohol dependency or other substance use disorder (score ≥ 5 on NM-ASSIST)
- Cognitive impairment (T-MoCA Short <10)
- Acute suicidal risk (positive screen ASQ Tool)
- History of psychosis or bipolar disorder
- Previously enrolled in the study
- Unable to provide written informed consent
Where it is running
- Yale New Haven Health Hospital — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.